Deborah L. Birx
Board Member
Armata Pharmaceuticals, Inc. (ARMP)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Deborah L. Birx
Deborah L. Birx is recorded as Board Member and CEO at Armata Pharmaceuticals, Inc. (ARMP). Earlier roles on record: Board Member at Innoviva, Inc. (INVA) until July 10, 2023. Armata Pharmaceuticals, Inc. reported in an 8-K filed July 11, 2023 that Deborah L. Birx was appointed Board of Directors. Armata Pharmaceuticals, Inc. reported in an 8-K filed July 11, 2023 that Deborah L. Birx was appointed Chief Executive Officer. Innoviva, Inc. reported in an 8-K filed July 11, 2023 that Deborah L. Birx resigned as member of the Board of Directors of Innoviva, Inc. and chair of the Audit Committee, effective July 10, 2023. The proxy statement of Armata Pharmaceuticals, Inc. reports total compensation of $1,584,176 for Deborah L. Birx in fiscal 2024, including a base salary of $546,000. Disclosed compensation is on record for 2 fiscal years.
“Dr. Birx will also join Armata's Board of Directors.”
“Armata also announced today a leadership transition whereby Dr. Deborah L. Birx will succeed Dr. Brian Varnum as Chief Executive Officer of the Company, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Current
Start not stated–present
-
Start not stated–2023-07-10
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Armata Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Deborah Birx CEO
- Dr. Deborah Birx CEO, Board Member
- Richard J. Bastiani Chairman
- David House CFO
- Julianne Averill CFO
- Richard Rychlik CFO
- Erin Butler Chief Accounting Officer
- Daniel Gilmer Board Member
- Dr. Daniel Gilmer Board Member
- Joseph M. Patti Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Armata Pharmaceuticals, Inc. (ARMP) | Chief Executive Officer | $546,000 | $1,584,176 |
| 2023 | Armata Pharmaceuticals, Inc. (ARMP) | Chief Executive Officer | $251,563 | $1,133,931 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.